A Fuchsia Howard, Joan L Bottorff, Lynda G Balneaves, Charmaine Kim-Sing. BMC Womens Health 2010
Times Cited: 21
Times Cited: 21
Times Cited
Times Co-cited
Similarity
Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review.
A Fuchsia Howard, Lynda G Balneaves, Joan L Bottorff. J Genet Couns 2009
A Fuchsia Howard, Lynda G Balneaves, Joan L Bottorff. J Genet Couns 2009
38
28
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
28
Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.
A Fuchsia Howard, Lynda G Balneaves, Joan L Bottorff, Patricia Rodney. Qual Health Res 2011
A Fuchsia Howard, Lynda G Balneaves, Joan L Bottorff, Patricia Rodney. Qual Health Res 2011
28
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
D Gareth R Evans, Fiona Lalloo, Linda Ashcroft, Andrew Shenton, Tara Clancy, Andrew D Baildam, Anne Brain, Penelope Hopwood, Anthony Howell. Cancer Epidemiol Biomarkers Prev 2009
D Gareth R Evans, Fiona Lalloo, Linda Ashcroft, Andrew Shenton, Tara Clancy, Andrew D Baildam, Anne Brain, Penelope Hopwood, Anthony Howell. Cancer Epidemiol Biomarkers Prev 2009
23
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
23
Surveillance or surgery? A description of the factors that influence high risk premenopausal women's decisions about prophylactic oophorectomy.
N Hallowell, I Jacobs, M Richards, J Mackay, M Gore. J Med Genet 2001
N Hallowell, I Jacobs, M Richards, J Mackay, M Gore. J Med Genet 2001
23
What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy.
Danielle Campfield Bonadies, Anne Moyer, Ellen T Matloff. Fam Cancer 2011
Danielle Campfield Bonadies, Anne Moyer, Ellen T Matloff. Fam Cancer 2011
23
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
23
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
19
Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.
Yoland Antill, John Reynolds, Mary-Anne Young, Judy Kirk, Katherine Tucker, Tarli Bogtstra, Shirley Wong, Tracy Dudding, Juliana Di Iulio, Kelly-Anne Phillips. Eur J Cancer 2006
Yoland Antill, John Reynolds, Mary-Anne Young, Judy Kirk, Katherine Tucker, Tarli Bogtstra, Shirley Wong, Tracy Dudding, Juliana Di Iulio, Kelly-Anne Phillips. Eur J Cancer 2006
19
Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.
Rebekah Hamilton, Janet K Williams, Barbara J Bowers, Kathleen Calzone. J Genet Couns 2009
Rebekah Hamilton, Janet K Williams, Barbara J Bowers, Kathleen Calzone. J Genet Couns 2009
19
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
19
Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
Angela R Bradbury, Comfort N Ibe, James J Dignam, Shelly A Cummings, Marion Verp, Melody A White, Grazia Artioli, Laura Dudlicek, Olufunmilayo I Olopade. Genet Med 2008
Angela R Bradbury, Comfort N Ibe, James J Dignam, Shelly A Cummings, Marion Verp, Melody A White, Grazia Artioli, Laura Dudlicek, Olufunmilayo I Olopade. Genet Med 2008
19
A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy.
N Hallowell. Psychooncology 2000
N Hallowell. Psychooncology 2000
19
Conditions and consequences of a BRCA mutation in young, single women of childbearing age.
Rebekah Hamilton, Karen E Hurley. Oncol Nurs Forum 2010
Rebekah Hamilton, Karen E Hurley. Oncol Nurs Forum 2010
19
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Marc D Schwartz, Heiddis B Valdimarsdottir, Tiffani A DeMarco, Beth N Peshkin, William Lawrence, Jessica Rispoli, Karen Brown, Claudine Isaacs, Suzanne O'Neill, Rebecca Shelby,[...]. Health Psychol 2009
Marc D Schwartz, Heiddis B Valdimarsdottir, Tiffani A DeMarco, Beth N Peshkin, William Lawrence, Jessica Rispoli, Karen Brown, Claudine Isaacs, Suzanne O'Neill, Rebecca Shelby,[...]. Health Psychol 2009
19
The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.
Robert Klitzman, Wendy Chung. Am J Med Genet A 2010
Robert Klitzman, Wendy Chung. Am J Med Genet A 2010
19
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Tara M Friebel, Susan M Domchek, Susan L Neuhausen, Theresa Wagner, D Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Clin Breast Cancer 2007
Tara M Friebel, Susan M Domchek, Susan L Neuhausen, Theresa Wagner, D Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Clin Breast Cancer 2007
14
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.
Timothy R Rebbeck, Noah D Kauff, Susan M Domchek. J Natl Cancer Inst 2009
Timothy R Rebbeck, Noah D Kauff, Susan M Domchek. J Natl Cancer Inst 2009
14
Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Lottie Lubsen-Brandsma, Leon F Massuger, Marian J E Mourits, Katja N Gaarenstroom, Eleonora B L van Dorst, Hans van der Putten,[...]. J Clin Oncol 2007
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Lottie Lubsen-Brandsma, Leon F Massuger, Marian J E Mourits, Katja N Gaarenstroom, Eleonora B L van Dorst, Hans van der Putten,[...]. J Clin Oncol 2007
14
An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.
Kate Brain, Clare Gravell, Elizabeth France, Alison Fiander, Jonathon Gray. Gynecol Oncol 2004
Kate Brain, Clare Gravell, Elizabeth France, Alison Fiander, Jonathon Gray. Gynecol Oncol 2004
18
Risk-reduction surgery decisions in high-risk women seen for genetic counseling.
Jessica A Ray, Lois J Loescher, Molly Brewer. J Genet Couns 2005
Jessica A Ray, Lois J Loescher, Molly Brewer. J Genet Couns 2005
14
Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy.
Sheri A Babb, Elizabeth M Swisher, Hope N Heller, Alison J Whelan, David G Mutch, Thomas J Herzog, Janet S Rader. J Genet Couns 2002
Sheri A Babb, Elizabeth M Swisher, Hope N Heller, Alison J Whelan, David G Mutch, Thomas J Herzog, Janet S Rader. J Genet Couns 2002
15
New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.
Suzanne M Miller, Pagona Roussi, Mary B Daly, John Scarpato. Clin Cancer Res 2010
Suzanne M Miller, Pagona Roussi, Mary B Daly, John Scarpato. Clin Cancer Res 2010
14
Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. J Clin Oncol 2004
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. J Clin Oncol 2004
14
Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
K A Metcalfe, A Poll, A O'Connor, S Gershman, S Armel, A Finch, R Demsky, B Rosen, S A Narod. Clin Genet 2007
K A Metcalfe, A Poll, A O'Connor, S Gershman, S Armel, A Finch, R Demsky, B Rosen, S A Narod. Clin Genet 2007
14
Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment.
Cheryl B Crotser, Suzanne S Dickerson. J Nurs Scholarsh 2010
Cheryl B Crotser, Suzanne S Dickerson. J Nurs Scholarsh 2010
21
Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
B Meiser, P Butow, M Price, B Bennett, G Berry, K Tucker. J Womens Health (Larchmt) 2003
B Meiser, P Butow, M Price, B Bennett, G Berry, K Tucker. J Womens Health (Larchmt) 2003
14
Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing.
A-B Skytte, A-M Gerdes, M K Andersen, L Sunde, K Brøndum-Nielsen, M Waldstrøm, S Kølvraa, D Crüger. Clin Genet 2010
A-B Skytte, A-M Gerdes, M K Andersen, L Sunde, K Brøndum-Nielsen, M Waldstrøm, S Kølvraa, D Crüger. Clin Genet 2010
14
Decision making and coping in healthcare: the Coping in Deliberation (CODE) framework.
Jana Witt, Glyn Elwyn, Fiona Wood, Kate Brain. Patient Educ Couns 2012
Jana Witt, Glyn Elwyn, Fiona Wood, Kate Brain. Patient Educ Couns 2012
14
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
14
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
14
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
14
Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
14
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
14
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
14
Decision aids for people facing health treatment or screening decisions.
Dawn Stacey, France Légaré, Krystina Lewis, Michael J Barry, Carol L Bennett, Karen B Eden, Margaret Holmes-Rovner, Hilary Llewellyn-Thomas, Anne Lyddiatt, Richard Thomson,[...]. Cochrane Database Syst Rev 2017
Dawn Stacey, France Légaré, Krystina Lewis, Michael J Barry, Carol L Bennett, Karen B Eden, Margaret Holmes-Rovner, Hilary Llewellyn-Thomas, Anne Lyddiatt, Richard Thomson,[...]. Cochrane Database Syst Rev 2017
14
Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
Marleah Dean, Lindy G Davidson. Health Commun 2018
Marleah Dean, Lindy G Davidson. Health Commun 2018
14
Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jillian T Henderson, Elizabeth M Webber, George F Sawaya. JAMA 2018
Jillian T Henderson, Elizabeth M Webber, George F Sawaya. JAMA 2018
14
Time to decide about risk-reducing mastectomy: a case series of BRCA1/2 gene mutation carriers.
Mary McCullum, Joan L Bottorff, Mary Kelly, Stephanie A Kieffer, Lynda G Balneaves. BMC Womens Health 2007
Mary McCullum, Joan L Bottorff, Mary Kelly, Stephanie A Kieffer, Lynda G Balneaves. BMC Womens Health 2007
13
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Kelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, Henry Lynch, Charmaine Kim-Sing, Eitan Friedman, William D Foulkes, Susan Domchek, Peter Ainsworth, Claudine Isaacs,[...]. J Clin Oncol 2008
Kelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, Henry Lynch, Charmaine Kim-Sing, Eitan Friedman, William D Foulkes, Susan Domchek, Peter Ainsworth, Claudine Isaacs,[...]. J Clin Oncol 2008
9
The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited.
N Hoogerbrugge, Y J L Kamm, P Bult, K M Landsbergen, E M H F Bongers, H G Brunner, H J Bonenkamp, J A de Hullu, M J L Ligtenberg, C Boetes. Ann Oncol 2008
N Hoogerbrugge, Y J L Kamm, P Bult, K M Landsbergen, E M H F Bongers, H G Brunner, H J Bonenkamp, J A de Hullu, M J L Ligtenberg, C Boetes. Ann Oncol 2008
9
Breast cancer prevention: patient decision making and risk communication in the high risk setting.
Elissa M Ozanne, Eve Wittenberg, Judy E Garber, Jane C Weeks. Breast J 2010
Elissa M Ozanne, Eve Wittenberg, Judy E Garber, Jane C Weeks. Breast J 2010
10
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Andrea Eisen, Jan Lubinski, Jan Klijn, Pal Moller, Henry T Lynch, Kenneth Offit, Barbara Weber, Tim Rebbeck, Susan L Neuhausen, Parviz Ghadirian,[...]. J Clin Oncol 2005
Andrea Eisen, Jan Lubinski, Jan Klijn, Pal Moller, Henry T Lynch, Kenneth Offit, Barbara Weber, Tim Rebbeck, Susan L Neuhausen, Parviz Ghadirian,[...]. J Clin Oncol 2005
9
Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Sining Chen, Edwin S Iversen, Tara Friebel, Dianne Finkelstein, Barbara L Weber, Andrea Eisen, Leif E Peterson, Joellen M Schildkraut, Claudine Isaacs, Beth N Peshkin,[...]. J Clin Oncol 2006
Sining Chen, Edwin S Iversen, Tara Friebel, Dianne Finkelstein, Barbara L Weber, Andrea Eisen, Leif E Peterson, Joellen M Schildkraut, Claudine Isaacs, Beth N Peshkin,[...]. J Clin Oncol 2006
9
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
9
Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.
K Tiller, B Meiser, P Butow, M Clifton, B Thewes, M Friedlander, K Tucker. Gynecol Oncol 2002
K Tiller, B Meiser, P Butow, M Clifton, B Thewes, M Friedlander, K Tucker. Gynecol Oncol 2002
9
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
9
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.